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Abstract 
This paper presents life expectancy forecasts for all countries in the world explicitly 
assuming mortality convergence. We develop a model that takes into account country-
specific heterogeneity in life expectancy historical trajectories, between-countries 
heterogeneity across gains and uncertainty through experts’ based arguments (Lutz et al. 
2001). The relevant literature has focused on forecasting mortality for a single 
population. Exception to this rule is the work by Li and Lee (2005) where the authors 
develop mortality forecasts that take into account patterns in a larger group using the 
Lee-Carter model. 
Torri and Vaupel (2012) argue that life expectancy in different countries tends to be 
positively correlated and forecast life expectancies in individual countries by forecasting 
the best-practice level and the gap between the national performance and the best-
practice level. We build upon their work by varying the speed of convergence, taking 
into account differential rates of linear increase in life expectancy across group of 
countries. 
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Forecasting Mortality Convergence up to 2100 
Alessandra Garbero and Warren Sanderson 
1 Introduction 
In summer 2011, a global Internet survey on the likely future trends in fertility, 
mortality, and migration and the main factors behind them was conducted among the 
members of major population associations and selected other professional organizations. 
The survey, a collaboration between the International Institute for Applied Systems 
Analysis’ (IIASA) World Population Program and Oxford University, constitutes a 
basis for new population forecasts by age, sex, and level of education for most of the 
countries of the world and the provinces of India and China. By allowing a large 
number of experts to participate and by providing an “argument-based” underpinning of 
numerical estimates about future trends in life expectancy in high and low mortality 
countries, the survey addresses two common weaknesses of population projection-
making: 1) a very limited or no theoretical foundation and 2) a participation of a small 
and often closed group of experts formulating the parameters of projection scenarios.  
This “argument-based” approach to produce probabilistic population projections 
has been developed and refined at IIASA over the past decade. Nathan Keyfitz and 
Andrei Rogers laid out the methodological foundations during the 1970s and early 
1980s, and later Wolfgang Lutz translated these concepts into sets of systematic 
numerical population forecasts for world regions. In general, introducing experts’ 
opinions within population forecasting offers the useful advantage of providing a wealth 
of information, demographic as well as epidemiological, at least in a qualitative way. A 
limitation is its potential of being prone to bias, namely experts’ subjectivity or their 
need to conform (for a review see Booth and Tickle 2008).  
In order to reduce bias, Lutz and Scherbov (1998) proposed Delphi-methods to 
draw on a wider expertise, thereby averaging out expert opinions.  
In this paper, we put greater emphasis on experts’ arguments rather than 
opinions as in successive developments of the methodology (Lutz et al. 2001; Lutz and 
Goldstein 2004). Experts’ arguments have been shown to increase the range of 
expectations. Experts’ expectations approximate population-level behavior and have 
been found to be particularly suited for medium to longer term forecasting (Booth and 
Tickle 2008). 
As part of this endeavor to produce a new set of argument-based population 
forecasts, a number of workshops were organized to validate ex-post the estimates in the 
survey given by the source experts. Leading experts in the field were asked to comment 
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upon and reach consensus about the future of life expectancy in high and low mortality1 
countries in two meetings, held respectively in Cape Town, South Africa (February 
2012) and in San Jose, Costa Rica (February 2012). In the Costa Rica meeting, the 
majority of experts agreed on a general paradigm of mortality convergence.  
The concept of convergence is central to the demographic transition theory and 
the presence of a global mortality convergence has been largely documented (Wilson 
2001). This idea initially arose from analyses that were performed on mortality data 
starting from the 1960s mostly coming from developed countries (McMichael et al. 
2004). In addition, the occurrence of a common pattern, named the “epidemiological 
transition” (Omran 1971), with the latter term broadly indicating falling death rates 
from infection diseases (mostly linked to young ages and premature mortality) to 
increasing deaths from non-communicable disease (largely occurring in old-age), gave 
some expectation of a rapid decline of mortality in high mortality countries as well, and 
stagnation for countries which already achieved a relatively low level of mortality.  
Although the idea of a global mortality convergence is widely acknowledged 
(Wilson 2001), there have been relatively few attempts to deal with convergence 
explicitly (Wilson 2001; Heuveline 1999; Oeppen 2006). On the other hand, the concept 
of convergence has been largely employed in the economics literature and particularly 
in the empirical literature on economic growth (Barro and Sala-I-Martin 1995; Landau 
et al. 1996). In the latter there are two main concepts of convergence; the first one, beta-
convergence, occurs when the growth rate of the variable of interest (normally the 
growth rate in GDP) depends negatively on its prior value. Controlling for the influence 
of other factors this produces the case of conditional convergence, where the level of 
convergence depends on those other factors. The second concept is sigma-convergence, 
which occurs when the dispersion of the indicator decreases. It’s just a description, 
without any assumption on the functional relation, in contrast to the beta-convergence. 
In the literature (Anand and Ravallion 1993; Bidani and Ravallion 1997) there are 
different sub-concepts of sigma convergence.  
Using the concept of sigma-convergence in absolute terms, this paper produces 
female life expectancy forecasts for 159 countries in the world.  
Specifically we develop a multi-pronged methodology that takes into account 
country-specific heterogeneity in life expectancy historical trajectories of life-
expectancies, between-country heterogeneity across life expectancy gains and 
argument-based expert’ judgement (Lutz et al. 1998; Lutz et al. 2001).   
The literature on forecasting mortality has usually focused on forecasting 
mortality for a single population (for a review see Hyndman et al. 2011). Exception to 
this rule, is the work by Li and Lee (2005) where the authors argue that mortality 
trajectories and patterns are increasingly becoming more similar in closely related 
populations and therefore develop mortality forecasts that take into account patterns in a 
larger group using the Lee-Carter model (1992). In this paper, we go a step forward and 
forecast country-specific life expectancy within a regional framework.  
                                                 
1
 High and low mortality populations were separated on the basis of the level of child mortality in the year 
2010 according to the revised estimates from the Inter-agency Group for Child Mortality Estimation 
(IGME), with the threshold being 40 deaths per 1,000 children below age 5. 
 3 
In addition we take into account existing work by several authors (White 2002; 
Oeppen and Vaupel 2002; Lee 2003; Torri and Vaupel 2012). The latter have stressed 
three major points: the first is that life expectancy (record or average) appears to have 
changed linearly over long periods of time. The second is that “national mortality trends 
should be viewed in a larger international context rather than being analysed and 
projected individually” (Lee 2003). The third is that life expectancy in different 
countries tends to be positively correlated. Torri and Vaupel (2012) forecast life 
expectancies in individual countries by forecasting the best-practice level and the gap 
between the national performance and the best-practice level.  
We build upon the work by Torri and Vaupel (2012), by explicitly varying the 
speed of convergence i.e. taking into account differential rates of linear increase in life 
expectancy across group of countries. Other authors (Raftery et al. 2012; Lalic and 
Raftery 2011) have already stressed this point and highlighted that life expectancy has 
been increasing most quickly for countries with middle life expectancy (i.e. around 60 
years), and more slowly for countries with lower or higher levels. With respect to these 
authors, we subdivide countries between forerunners and laggards, propose a one-sex 
model and generate life expectancy forecasts that are a function of country-specific 
stochastic and structural trends in life expectancy as well as a function of stochastic and 
structural differences between forerunners and non-forerunners. Hence, we explicitly 
take into account different forms of heterogeneity: 1) the heterogeneity among 
forerunners-specific gains as well as among non-forerunners/laggards’ ones; 2) the 
relationship between the two, and 3) the heterogeneity across countries and regions. The 
model is explained in detail in the next section. 
2 Methodology 
Our forecasts are based on estimates of female life expectancy from 1950 to 2005 
(United Nations 2011).  
Specifically, we assume that country-specific life expectancy will converge to 
the one of the global forerunner by 2100. The global forerunner has been defined as “the 
best practice life expectancy” (BPL), a time series that includes Japan as well as other 
countries that historically exhibited the highest level of life expectancy during the 
period spanning from 1950 to 2005. The forecast for the global forerunner is based on a 
linear increase in life expectancy of two years per decade until 2100 (Oeppen and 
Vaupel 2002; Sanderson and Scherbov 2004).  
Although it is plausible to believe that low mortality countries will exhibit linear 
increases in life expectancy and will converge to an upper bound level of life 
expectancy by 2100, the paradigm is less applicable to high mortality countries. To this 
end, we developed the idea of a two-steps convergence process, where countries were 
subdivided into regional forerunners and laggards vis a vis the global forerunner. The 
idea is that laggards’ life expectancy will continue to grow as fast as in the regional 
forerunner. Regional forerunners were defined as countries that exhibited the highest 
life expectancies in 2005-2010 within each geographical region.  
The model is implemented as a dynamic panel data model, autoregressive of 
order 1, with fixed effects, which is estimated with 2-step GMM. The specification is 
the following and is estimated over the period 1980-2005: 
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∆�0��,�−1=  �∆�0�,�,�−1  + �(�0�,�−1 − �0�,�−1) + ��,� + �� 
Where �0�,� is the female life expectancy at birth for the forerunner i at time t �0�,� is the female life expectancy at birth for the country c at time t ∆�0��,�−1   is the change in female life expectancy at birth for the country c between t 
and t-1 ∆�0��,�−1   is the change in female life expectancy at birth for the forerunner i between t 
and t-1 ��,� is the time-varying error component �� are country-specific fixed effects.  
It is important to note that the equilibrium is reached when:  
(�0�,�−1 − �0�,�−1) =  (� − 1 )∆�0��,�−1  + ���  
The “beta term” is endogenous. In order to correct for the dynamic panel bias 
and auto-correlation, we instrument this term with its fourth and fifth lag. The Sargan-
Hansen test indicates that the instruments are valid, and the result from the endogeneity 
test corroborates the fact that the beta term is endogenous (the latter is defined as the 
difference of two Sargan-Hansen statistics: one for the equation with the smaller set of 
instruments, where the suspect regressor are treated as endogenous, and one for the 
equation with the larger set of instruments, where the suspect regressors are treated as 
exogenous). 
In summary, we are trying to estimate a model where life expectancy gains (or 
changes between t and t-1) for each country are regressed against the forerunner life 
expectancy gains controlling for the gap (the “beta term”) between the forerunner life 
expectancy and the country itself observed in the previous period (t-1). The lags are 
computed over the period from 1950 to 2005.  
Hence, convergence is achieved when the difference between country-specific 
life expectancy and the forerunner is no longer changing. In essence, we have a model 
in which only the mean of distribution of life expectancies changes over time, but the 
variance remains constant. In addition, our model does not impose an upper limit. There 
is no convergence to the level of the forerunner, in part because the level is always 
changing. 
The added value of this convergence model lies in the fact that it is based on 
empirical data. In addition, it takes into account the heterogeneous country-specific 
historical experience as well as differences in gains between forerunners and laggards 
over time and across regions. Thus, it takes into account structural as well as stochastic 
components that contribute to life expectancy trends overtime and it is able to generate 
unbiased parameters upon which the new forecasts are based.  
  
 5 
3 Estimation Procedure  
The estimation procedure encompasses five steps.  
The first step involved generating the forerunners life expectancy forecasts 
(2010-2100).  
The second step involved generating life expectancy forecasts for the non-
forerunners. Separate regressions were conducted for Southern and South-East Asia to 
obtain region-specific parameters (2010-2100). 
The third step involved generating life expectancy forecasts for HIV-affected 
countries as well as high mortality countries such as Afghanistan (2050-2100).  
The forth step involved incorporating source experts and meta-experts opinions 
in the form of net gains in life expectancy, from the low and high mortality surveys 
(2020-2050). 
The final step consisted of recalibrating the future trajectories (2050-2095) based 
on new trend and estimated parameters, since experts opinions were only given until 
2050.  
Step 1: Generating forerunners life expectancy forecasts 
In order to generate the forerunners life expectancy forecasts, we estimated the 
model using as the global forerunner, a “best-practice” life expectancy (BPL) which 
includes Japan as well as other countries that historically exhibited the highest life 
expectancies during the period spanning from 1950 to 20052. The estimation sample for 
the first stage regressions included the following countries: 
  
                                                 
2
 Specifically: Norway (1950-55/1955-60); Iceland (1960-65), Sweden (1965-70/1970-75); Iceland 
(1975-80); Japan (1980-85 to 2005-10). 
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Table 1. Estimation sample  
Region Country 
Oceania Australia 
Caribbean Martinique 
Central America Costa Rica 
Central Asia Kazakhstan 
Eastern Africa Reunion; Mauritius; Mayotte; Madagascar 
Eastern Asia Japan 
Eastern Europe Czech Republic 
Melanesia New Caledonia 
Micronesia Guam 
Middle Africa Sao Tome and Principe; Gabon 
NORTHERN AMERICA Canada 
Northern Africa Libyan Arab Jamahiriya; Tunisia  
Northern Europe Iceland 
Polynesia French Polynesia 
South America Chile 
South-Eastern Asia Singapore 
Southern Africa Namibia 
Southern Asia Sri Lanka 
Southern Europe Italy 
Western Africa Cape Verde; Ghana 
Western Asia Israel 
Western Europe France 
 
This model fits the data well and succeeds in capturing historical converging 
trends across this set of countries. Exceptions are however some African countries 
(Madagascar and Ghana – while the fit for Namibia and Gabon is largely acceptable and 
surprisingly converging towards the UN forecast value in 2100). Given the presence of 
HIV and AIDS, we don’t assume convergence for the period 2010 to 2050 for HIV and 
AIDS affected countries as well as high mortality countries such as Haiti and 
Afghanistan. The latter are exceptions to the convergence theory, due to the occurrence 
of mortality reversals over the last two decades. Factors such as conflicts, failure of 
health systems and impact of HIV and AIDS epidemic have largely impeded progress in 
life expectancy in the past 20 years and will probably continue to impede it in the short 
term. For this subset of countries, the United Nations medium variant was adopted up to 
20503 (United Nations 2010). Therefore we deliberately endorse the UN medium 
                                                 
3
 Although India is considered an HIV and AIDS affected country in the UN medium variant scenario, we 
decided to explicitly model convergence for India as well, given the low prevalence of HIV. 
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scenario as the correct forecast, given the impact of mortality crisis which the model 
cannot capture.  
Therefore, based on the parameters obtained from this model, we produced 
forecasts for the regional leaders (Japan, Tunisia, Sri Lanka, French Polynesia, Guam, 
New Caledonia, Singapore, Costa Rica, Martinique, Kazakhstan, Israel, Reunion and 
Madagascar). As Madagascar represents an outlier in terms of its past mortality 
experience (Ranis and Stewart 2000), we imposed an average parameter which 
summarizes the historical experience of the African forerunners (i.e. Tunisia, Reunion, 
Mauritius, Gabon, Ghana, Sao Tome and Principe and Cape Verde).  
Table 2. Forerunners for second-stage regression 
Europe & North America: Japan  
Northern Africa (including Sudan): Tunisia 
Eastern Africa: Madagascar 
Western Africa: Ghana 
Middle Africa: Gabon 
Southern Africa: Namibia 
Southern Asia: Sri Lanka 
Polynesia: French Polynesia 
Micronesia: Guam 
Melanesia: New Caledonia 
South-Eastern Asia: Singapore   
South America/Central America: Costa Rica 
Caribbean: Martinique 
Western Asia: Israel 
Central Asia: Kazakhstan 
Hybrid group (including Cape Verde, Comoros, Mauritius, Mayotte, Sao Tome and Principe): Reunion 
 
Step 2: Generating non-forerunners life expectancy forecasts 
The second step involved running the model on all the remaining countries. We 
stratified the model by region i.e. Southern Asia, South-East Asia and the remaining 
countries (excluding countries that belong to the HIV-affected group as well as Haiti 
and Afghanistan). This time the regional forerunners life expectancies were chosen as 
“best-practice” life expectancies for each region. Based on the parameters obtained from 
the second stage regression, we generated forecasts up to 2100.  
Step 3: Generating non-forerunners life expectancy forecasts (HIV and 
AIDS affected countries and Afghanistan 
The third step involved generating life expectancy forecasts from 2050 to 2100, 
for HIV-affected countries and high mortality countries such as Haiti and Afghanistan. 
We explicitly assume convergence for this projection interval. Namibia was chosen as a 
forerunner for this set of countries for three reasons. First, its high life expectancy 
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across the period 2005-2010 in the entire Sub-Saharan Africa region (United Nations 
2011); second, for its high levels of anti-retroviral treatment provision in 2010 to the 
large percentage of affected population (UNAIDS 2010); third, for its large investments 
in the health sector (GHI 2011). We retrieved the structural parameter that is implicit 
from the first step regression and imposed it for the period 2050-2100. This parameter 
embodies all unobserved characteristics (for instance success of health care system, 
economic growth, education expansion) that characterize life expectancy gains in 
Namibia. By retrieving this parameter and using the Namibian forecast as well the 
parameters beta and gamma from the second stage regression we generated the 
structural parameters for the countries falling in this group and produced our forecasts 
from 2050-2100. Remarkably these forecasts are quite close to the UN ones for the 
period 2050-2100.  
Step 4: Incorporating uncertainty through an experts’ based argument 
approach 
The fourth and quite important step involved the reweighting of these forecasts 
in order to incorporate source experts and meta-experts arguments in the form of life 
expectancy net gains. Through this step, we aim at incorporating uncertainty in our 
forecasts based on an expert-based argument methodology (Lutz et al. 2001).  
In order to take into account source experts (i.e. experts that answered the 
survey) and meta-experts (i.e. experts that attended the workshops) numerical estimates 
(decadal gains in life expectancy), we implemented a framework that operationalizes 
source-experts and meta-experts arguments and combines their estimates with our life 
expectancy forecasts.  
Analytically, given model gains �0� �,�, which consist of the model gains 
implied by our forecasts for all countries except Sub-Saharan Africa, Haiti and 
Afghanistan, and the ones implied by UN medium scenario for the other set of 
countries, we reweighted model gains (from 2010-2050) to obtain new model 
gains ��0�:  ��0�= 1 ∗  �0� �,� +0.2 ∗ ������������������,� + 1 ∗ ���������������,�)/∑����ℎ�� 
Where ������������������,� are the net gains as given by the source experts in the 
low and high mortality surveys. The latter were given a weight of 0.2. ���������������,� is the average of the net gains as given by the meta-experts4 in 
the low and high mortality surveys. The latter are given a weight of 1.  
                                                 
4
 One additional complication was that the metric was different (gains versus life expectancy point 
estimates) as meta-experts gave only predicted life expectancy for both sexes for two point estimates (i.e. 
2030 and 2050) for high mortality countries. Therefore, we calculated the e0 differential (female life 
expectancy - total) in 2005 and derived predicted female life expectancy (assuming that this difference 
remains constant to the 2005 level). We then performed quadratic interpolation to reconstruct “missing” 
net gains. In addition, we kept the model gains until 2015 for HIV and AIDS affected countries and then 
interpolated between 2015 and first available gain (2020) given by the experts – hence, there is difference 
in the magnitude of gains between our predicted gains and the ones implied by the UN medium scenario 
until 2050. 
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Also model gains �0� �,� are given a weight of 1. The magnitude of these weights was 
assessed through a sensitivity analysis.  
The new model gains were then employed to adjust the model forecasts up to 2050. 
Step 5: Generating forecasts for all countries for the period 2050-2100 
The final step consisted of modifying the future trajectories (2050-2095) based 
on the new trend implied by the reweighted forecasts up to 2050. We computed the 
structural parameter (fixed effect) which is implied by the new forecast (2010-2050) and 
combined with the parameters (beta and gamma) that have been estimated throughout 
the various phases of our procedure to obtain forecasts for the period 2050-2100. 
4 Results 
We present results after the first step for the forerunners (Figure 1) and the overall 
procedure for the United States of America, Brazil, Botswana, Tajikistan, Ethiopia, 
China and Ghana (Figure 2 to Figure 8). The final set of graphs (Figures 2 to 8) present 
our final forecast (final) i.e. after step 5, the model value obtained after step 3 (model), 
the UN life expectancy value (UN), and the forerunner life expectancy (BPL). For 
countries with no experts’ numerical estimates5, the procedure stops after the third step 
(i.e. model values coincide with our final forecast value) hence the resulting three lines 
in the figures.   
Figure 1 shows the forerunners forecasts after the first step of the procedure. For 
HIV and AIDS affected countries this first step is only illustrative of how the model fits 
the data and how the forecasts would look, had we employed the parameters to generate 
the forecasts. For instance, the final forecast for Ghana is presented in Figure 8 after 
step 5 is implemented (i.e. reweighting due to experts’ predicted decadal gains and 
calibration of trend after 2050).  
Figure 2 (United States) shows how historically the United States diverged from 
Japan. However our model is generally optimistic in generating linear gains and a 
parallel line. For this country, we had the largest number of experts in the low mortality 
survey. The latter provided a distribution of decadal gains in life expectancy for 2020-
30 and 2040-50. After adjusting the model forecast taking into account experts’ 
numerical estimates, the forecast is adjusted downward indicating their pessimistic 
view.  
In Brazil, Figure 3, experts had provided a more optimistic outlook about the 
future of life expectancy, which results in an adjustment upward of our model forecast.  
As far as Botswana, Ghana and Ethiopia were concerned, experts were largely 
pessimistic (resulting in an adjustment downward of the line). However our model 
results did not exclude a possible catch up in the period 2050-2100.  
In general, our forecasts are largely optimistic when compared to the United 
Nations’ ones. Exceptions are HIV and AIDS affected countries, Sub-Saharan Africa as 
well as high mortality countries such as Afghanistan. In these instances, our final 
forecast values are either lower, or in substantial agreement (i.e. Afghanistan and Haiti). 
                                                 
5
 The low and high mortality surveys provided data only for 30 and 14 countries respectively.  
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Figures 1a-d. Step 1 - Forerunners forecasts (Model forecast, UN medium scenario vs. 
global forerunner e0 -BPL) 
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Figure 2. United States of America (BPL: Japan) 
 
Figure 3. Brazil (BPL: Costa Rica) 
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Figure 4. Botswana (BPL: Namibia) 
 
Figure 5. Tajikistan (BPL: Kazakhstan)  
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Figure 6. Ethiopia (BPL: Madagascar) 
 
Figure 7. China (BPL: Japan) 
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Figure 8. Ghana (BPL: Global forerunner) 
 
5 Discussion 
We have developed an econometric model that operationalizes the concept of mortality 
convergence for 159 countries in the world explicitly varying the speed of convergence 
i.e. taking into account differential rates of linear increase in life expectancy across 
group of countries. The model is grounded on empirical data and produces life 
expectancy forecasts which are a function of country-specific stochastic and structural 
trends in female life expectancy, as well as a function of stochastic and structural 
differences between forerunners and non-forerunners. Therefore, the model takes into 
account country-specific and between countries heterogeneity at various levels and it is 
econometrically unbiased.  
 For countries with generalized HIV and AIDS epidemics (38 countries), we 
don’t assume convergence for the period 2010 to 2050. For the latter, we endorse the 
United Nations medium scenario, which explicitly models the impact of HIV and AIDS 
with an epidemiological model (Alkema et al. 2007; Brown et al. 2010; Raftery and Bao 
2010).  
 Our model incorporates uncertainty through an expert-based approach. To this 
end, experts were asked to participate and provide an argument-based underpinning of 
numerical estimates about future trends in life expectancy in high and low mortality 
countries. Therefore, we develop a framework that operationalizes source-experts and 
meta-experts opinions and combines their estimates with our life expectancy forecasts. 
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 The methodology proposed essentially presents a formal framework where 
extrapolative methods are combined with expert-based argument approaches. In 
addition, it is based on empirical data, it is replicable, relatively simple and transparent.  
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